Dolors Colomer

Active 1996–2025

130
Papers
24,081
Citations
84
h-index
129
i10-index

Citations

Citations per year for Dolors Colomer1959: 1 citations1978: 1 citations1979: 1 citations1996: 1 citations1997: 3 citations1998: 18 citations1999: 21 citations2000: 21 citations2001: 23 citations2002: 55 citations2003: 93 citations2004: 113 citations2005: 141 citations2006: 198 citations2007: 240 citations2008: 249 citations2009: 198 citations2010: 181 citations2011: 216 citations2012: 251 citations2013: 301 citations2014: 244 citations2015: 246 citations2016: 269 citations2017: 230 citations2018: 186 citations2019: 614 citations2020: 658 citations2021: 587 citations2022: 454 citations2023: 356 citations2024: 535 citations2025: 211 citations2026: 7 citations1960–1977: no citations, so these years are not shown1980–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,321 citing papers, 24% of this breakdownGermany: 766 citing papers, 7.9% of this breakdownSpain: 728 citing papers, 7.5% of this breakdownUnited Kingdom: 697 citing papers, 7.2% of this breakdownItaly: 673 citing papers, 7% of this breakdownChina: 602 citing papers, 6.2% of this breakdownFrance: 490 citing papers, 5.1% of this breakdownCanada: 273 citing papers, 2.8% of this breakdownNetherlands: 267 citing papers, 2.8% of this breakdownAustralia: 255 citing papers, 2.6% of this breakdownSwitzerland: 223 citing papers, 2.3% of this breakdownJapan: 197 citing papers, 2% of this breakdown
0%24%Other 22.6%

Fields

  • Medicine51.9%
  • Biochemistry, Genetics and Molecular Biology41.4%
  • Immunology and Microbiology3.8%
  • Agricultural and Biological Sciences0.7%
  • Neuroscience0.4%
  • Engineering0.4%
  • Other1.4%

Topics

  • Chronic Lymphocytic Leukemia Research7.8%
  • Lymphoma Diagnosis and Treatment7.3%
  • Epigenetics and DNA Methylation5%
  • Acute Myeloid Leukemia Research4.4%
  • RNA modifications and cancer2.7%
  • Histone Deacetylase Inhibitors Research2.6%
  • Other70.2%

Coauthors

All papers

Open in search
  1. An atlas of cells in the human tonsil

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hamish W. King, Lucy C. Garner, Fédérico Marini, Francisco Javier Cervera‐Paz, Peter Baptista, Isabel Vilaseca, Cecilia Rosales, Sílvia Ruiz-Gaspà, Benjamin James Talks, Keval Sidhpura, Anna Pascual Reguant, Anja E. Hauser, Muzlifah Haniffa, Felipe Prósper, Ralf Küppers, Marta Gut, Elı́as Campo, José I. Martín‐Subero, Holger Heyn - Immunity 2024 cited by 156

  2. Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Immunity 2021 cited by 130

  3. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2005 cited by 1,911

  4. Detection of early seeding of Richter transformation in chronic lymphocytic leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francesc Bosch, Marta Aymerich, Anna Enjuanes, Sílvia Ruiz-Gaspà, Armando López‐Guillermo, Pedro Jares, Sı́lvia Beà, Salvador Capella-Gutiérrez, Josep Lluis Gelpí, Núria López-Bigas, David Torrents, Peter J. Campbell, Marta Gut, Davide Rossi, Gianluca Gaïdano, Xosé S. Puente, Pablo M. García-Rovés, Dolors Colomer, Holger Heyn, Francesco Maura, José I. Martín‐Subero, Elı́as Campo - Nature Medicine 2022 cited by 135

  5. Non-coding recurrent mutations in chronic lymphocytic leukaemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Martin‐García, Alba Navarro, Pilar Nicolás, Modesto Orozco, Ángel Ramírez Páyer, Magda Pinyol, David G. Pisano, Diana Puente, Ana C. Queirós, Vı́ctor Quesada, Carlos Romeo-Casabona, Cristina Royo, Romina Royo, Marı́a Rozman, Núria Russiñol, Itziar Salaverría, Κώστας Σταματόπουλος, Hendrik G. Stunnenberg, David Tamborero, María José Terol, Alfonso Valencia, Núria López-Bigas, David Torrents, Marta Gut, Armando López‐Guillermo, Carlos López-Otı́n, Elı́as Campo - Nature 2015 cited by 858

  6. Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elı́as Campo - Blood 2020 cited by 216

  7. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Luís Hernández, Jordi Yagüe, Pilar Nicolás, Carlos Romeo-Casabona, Heinz Himmelbauer, Ester Castillo, Juliane C. Dohm, Silvia de Sanjosé, Miguel Á. Piris, Enrique de Alava, Jesús F. San Miguel, Romina Royo, Josep Lluis Gelpí, David Torrents, Modesto Orozco, David G. Pisano, Alfonso Valencia, Roderic Guigó, Mónica Bayés, Simon Heath, Marta Gut, Peter Klatt, John Marshall, Keiran Raine, Lucy Stebbings, P. Andrew Futreal, Michael R. Stratton, Peter J. Campbell, Marta Gut, Armando López‐Guillermo, Xavier Estivill, Emili Montserrat, Carlos López-Otı́n, Elı́as Campo - Nature 2011 cited by 1,527

  8. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alfonso Valencia, Heinz Himmelbauer, Mónica Bayés, Simon Heath, Marta Gut, Marta Gut, Xavier Estivill, Armando López‐Guillermo, Xosé S. Puente, Elı́as Campo, Carlos López-Otı́n - Nature Genetics 2011 cited by 996

  9. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ana Muntañola, Elena Hartmann, Marı́a José Calasanz, Andreas Rosenwald, German Ott, Jesús María Hernández‐Rivas, Wolfgang Hiddemann, Reiner Siebert, Adrian Wiestner, Wyndham H. Wilson, Dolors Colomer, Armando López‐Guillermo, Carlos López-Otı́n, Xosé S. Puente, Elı́as Campo - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 519

  10. Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 162

  11. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Modesto Orozco, Jian‐Bing Fan, Vı́ctor Quesada, Xosé S. Puente, David G. Pisano, Alfonso Valencia, Armando López‐Guillermo, Marta Gut, Carlos López-Otı́n, Elı́as Campo, José I. Martín‐Subero - Nature Genetics 2012 cited by 589

  12. The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status

    Authors: , , , , , - Blood 2005 cited by 467

  13. The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , - Leukemia 2021 cited by 66

  14. Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2016 cited by 333

  15. Sampling time-dependent artifacts in single-cell genomics studies

    Authors: , , , , , , , , , , , , , , , - Genome biology 2020 cited by 95

  16. Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy

    Authors: , , , , , , , , , , , , , , , , , , , - Blood 2013 cited by 282

  17. International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia

    Authors: , , , , , , , , , , , , , , , , , , , , , - Leukemia 2007 cited by 399

  18. EOMES is essential for antitumor activity of CD8+ T cells in chronic lymphocytic leukemia

    Authors: , , , , , , , , , , , , - Leukemia 2021 cited by 54

  19. EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4+ T cells in chronic lymphocytic leukemia

    Authors: , , , , , , , , , , , , , , , , , - Leukemia 2021 cited by 48

  20. A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elı́as Campo, Armando López‐Guillermo, José I. Martín‐Subero - Leukemia 2014 cited by 157

  21. The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma

    Authors: , , , , , , , , , , , - Cell Death and Differentiation 2013 cited by 139

  22. A novel patient-derived 3D model recapitulates mantle cell lymphoma lymph node signaling, immune profile and in vivo ibrutinib responses

    Authors: , , , , , , , , , , , , , , , , , , - Leukemia 2023 cited by 28

  23. Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , - Leukemia 2015 cited by 342

  24. Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies

    Authors: , , , - Haematologica 2020 cited by 98